Status:
UNKNOWN
Relationship Between D2 Receptors SPECT and the Apomorphine Test in Patients With OH Dependence (ALC-DRD2-APO)
Lead Sponsor:
Hospital Universitari Vall d'Hebron Research Institute
Conditions:
Alcoholism
Eligibility:
MALE
25-60 years
Phase:
PHASE2
Brief Summary
OH dependence is associated with DA receptor changes. Both, the apomorphine test and the D2Rec SPECt are usefull for monitoring DA receptor status. We aimed at studying whether DA receptor hypofunctio...
Eligibility Criteria
Inclusion
- alcohol dependence
- alcohol dependence length at least 8 years.
- male
- age 25 - 60 years
Exclusion
- other drug dependence (except nicotine dependence)
- another major axis I psychiatric diagnosis
- comorbid neurological disorder
- comorbid cardiovascular disorder
- comorbid metabolic disorder
- brain injury
- apomorphine allergy
- iode allergy
- diazepam allergy
Key Trial Info
Start Date :
January 1 2007
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 1 2010
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT00437177
Start Date
January 1 2007
End Date
June 1 2010
Last Update
April 29 2009
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Psychiatry Service, Hospital Universitari Vall d'Hebron
Barcelona, Catalonia, Spain, 08036